US Supreme Court Extends Mifepristone Access Temporarily with 2-Day Pause on Lower Court Ruling
April 20, 2023
The US Supreme Court has issued a 2-day pause on a lower ruling that would revoke the decades-old approval of mifepristone, a key component of the abortion pill. The stay would end at midnight this Friday, April 21st. The ruling has drawn substantial criticism, not the least of which is that allowing a judge to overturn approval by the US Food and Drug Administration (FDA) would undermine the agency’s authority to regulate medications.
According to Abbie VanSickle, “In their suit, the anti-abortion groups claimed that the F.D.A. did not follow proper protocols when it approved the drug in 2000. The groups said that the agency had also ignored dangers of the drug in the years since. The F.D.A., vigorously countering those claims, has said that the drug was properly approved more than 20 years ago and that it is very safe. It has cited years of scientific studies that show that serious complications are rare and that less than 1 percent of patients need hospitalization…”
To read more, click here.
(Source: The New York Times, April 19th, 2023)
